Squire Patton Boggs has advised Biocomposites (UK) Limited, a portfolio company of TA Associates, as strategic investor in the seed financing round of InfectoTest GmbH, a Berlin-based bio-med startup.
The team was led by Corporate partner Norman Wasse and senior associate Dr. Marion von Grönheim, supported by David Milne, Louise Parker, Josh Astill-Headley and Felix Strohecker (Corporate), Dr. Sandra Müller, Charlotte Firth and Christoph Krieger (Intellectual Property & Technology), Dagmar Nolden (Labour & Employment), Andreas Lehmann (Financial Services) and Dr. Matthias Werner (Real Estate).
Corporate partner Norman Wasse, who has proven expertise in the private equity and venture capital sector, has successfully advised portfolio companies of TA Associates on several investments. TA Associates is a leading global private equity firm is headquartered in Boston, USA.
Biocomposites is an international medical device company that engineers, manufactures and markets world leading products for regenerating bone and managing infection in bone and soft tissue. Based in Keele, UK, it has global operations across Europe, South America, USA, Canada, China and India.
InfectoTest GmbH is a biomedical company that develops innovative Point-of-Care diagnostic systems for the diagnosis of infectious diseases.